M.Sc

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field. 

Post : Executive - NCQ

AUROBINDO PHARMA LTD is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over USD 2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations.

Post : Executive /Senior Executive

Walk-In Interviews for Aurobindo Pharma Ltd I Unit-VII, Jadcherla

Lincoln Pharmaceuticals shares its presence with fellow foremost top notch excellence driven pharmaceutical producers, engaged in manufacturing and marketing several therapeutic molecules under WHO-GMP guidelines. What makes Lincoln stands apart is their commitment to deliver unsurpassed quality of innovative products for the betterment of human health. Our drugs are developed using best in class guidelines and all that at a very cost-effective rates.

Kwality’ was born on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business.  He received his first drug license in 1981 approved for liquid oral manufacturing. Climbing ladder of success, till date, Company has 48 different sections available at their production centres.

Ind-Swift Limited - Jawaharpur, Derabassi is the Ace unit of Ind-Swift Limited, was created in the year 2005 with an aim to globalize the Ind-Swift brand for finished dosage forms. We are a 100% Export Oriented Unit dealing in regulated markets having approval like MHRA, TGA & GLC etc.

OPEN POSITIONS for Formulation Site

After successful 12 editions of Pharma IT Summit, Exito is all set to host another milestone event- the 13th Edition of Pharma IT Summit, an in-person event organised under the theme Unleashing the Digital Revolution in Pharma. In the global pharmaceuticals sector, India is a significant and rising player. India is the world’s largest supplier of generic medications, accounting for 20% of the worldwide supply by volume and supplying about 60% of the global vaccination demand. The Indian pharmaceutical sector is worth US 42 billion USD worldwide.

Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) can trace its origins to the Ecole de Medicine de Pondicherry established by the French Government in 1823. In 1956 foundation for new medical college was laid and in 1964, hospital was inaugurated. JIPMER became an institution of national importance under the Ministry of Health and Family Welfare, Government of India in the year 2008. It is an institution established for teaching, research and patient care in the area of health. JIPMER spreads over 192 acres

CSIR-Central Drug Research Institute, Lucknow, a premier Institute under Council of Scientific and Industrial Research (CSIR), is involved in multidisciplinary R&D programs of both basic and applied nature. CSIR-CDRI is a pioneer biomedical research organization in India and has the infrastructure and expertise to develop a drug from concept to commercialization. In the year 2012, CSIR-CDRI shifted to its state of the art new campus, which has been set up with a vision to serve as a Nodal Center of CSIR in new drug discovery and development.

Abryl Laboratories was incorporated in 2016 with a single mission—to provide the global market with high quality sterile liquid and lyophilised products. Over the course of time, Abryl has expanded its operations to pre-filled syringes as well.  The project was conceptualised in 2016, followed by the construction commencement in 2017. By May 2019, within just two years, the facility was completely ready for beginning its operations.